AL-001(Beijing Anlong Biomedical)

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameAL-001(Beijing Anlong Biomedical)
Drug Alias NameAL-001
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionAnti-Vascular endothelial growth factor
TargetsVascular endothelial growth factor
Therapy Area/IndicationsWet age-related macular degenerationGeographic AtrophyDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBeijing Anlong Biomedical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Anlong Biomedical Co LtdBeijing Anlong Hesheng Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsWet age-related macular degenerationGeographic AtrophyDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A